Merck Establishes New Foundation for Global Healthcare Solutions
Merck Group announced the establishment of the Merck Foundation, a non-profit limited liability company. Through this foundation, Merck combines many of its corporate responsibility activities under one roof and considerably expands its scope to address health, social and economic challenges of the 21st century.
“The vision of the new foundation is the world where everyone can lead a healthy and fulfilling life, also those living under disadvantaged conditions,” said Frank Stangenberg-Haverkamp, chairman of the board of trustees of the new foundation.

“With the Merck Foundation, we will continue our commitment towards improving access to innovative healthcare solutions in underserved communities, building healthcare and scientific research capacity and advancing people’s lives through science and technology,” added Haverkamp.
“The Merck Foundation will focus on initiatives that will contribute towards the sustainable development goals outlined by the United Nations. To achieve the foundations’ goals, we will develop and implement coherent strategies, result oriented programs and initiatives, provide grants to support projects and help raise funds where needed,” said Rasha Kelej, who has been appointed CEO of the Merck Foundation.
Kelej (45) joined Merck in 1996, working exclusively in positions relevant to corporate responsibility and market development with a strong focus on Africa and developing countries.
Looking for chemical products? Let suppliers reach out to you!
2026-06-27
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Merck Establishes New Semiconductor Hub in Taiwan
-
Merck Completes Sale of Surface Solutions Business to GNMI for €665 Million
-
Merck and Siemens Collaborate on Smart Manufacturing
-
Merck sells Surface Solutions to Global New Material International for €665 million in cash
-
Merck Group acquires chip equipment supplier Unity-SC for €155 million
-
Merck Launches Commercial Production of First GMP-Compliant Cell Culture Media Production Line in China
-
Merck to acquire EyeBio for $3 billion
-
Circa signs OEM agreement with Merck to supply and sell Cyrene
-
The Rising Heat of DAC Drugs: ADC and PROTAC Sparking Innovation
-
Merck Expands Biosafety Testing Laboratory Center in Shanghai
Recommend Reading
-
ICIS Global No.58: ECHEMI Again Ranks Among the World’s Chemical Distributors
-
New Location, New Horizon: ECHEMI Thailand Branch Embarks on a New Chapter
-
China’s API Export Shift Takes Center Stage at API China 2026
-
Supporting Each Other | ECHEMI Employees Voluntarily Raise Funds for Flood Relief in Southern Thailand
-
Address Change Declaration(ECHEMI SPECIALTIES)
-
Asahi Kasei Draws the Line on HMD: Strategic Exit from Hexamethylenediamine Production Signals Portfolio Refocus
-
UBE Unveils Eco-Friendly Nylon and Materials with U-BE-INFINITY Certification
-
AkzoNobel Sells India Business to JSW Group in €1.4 Billion Deal
-
AkzoNobel Completes Sale of AkzoNobel India Limited to JSW Group
-
Premium Global Chemical Sourcing Requests (25-29 Oct 2025)